Jackson, W. C., Johnson, S. B., Li, D., Foster, C., Foster, B., Song, Y., . . . Feng, F. Y. (2013). A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy. BioMed Central.
Citação norma ChicagoJackson, William C., et al. A Prostate-specific Antigen Doubling Time of <6 Months Is Prognostic for Metastasis and Prostate Cancer-specific Death for Patients Receiving Salvage Radiation Therapy Post Radical Prostatectomy. BioMed Central, 2013.
MLA CitationJackson, William C., et al. A Prostate-specific Antigen Doubling Time of <6 Months Is Prognostic for Metastasis and Prostate Cancer-specific Death for Patients Receiving Salvage Radiation Therapy Post Radical Prostatectomy. BioMed Central, 2013.